BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 15999561)

  • 1. [Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL)].
    Sapir T; Carp H; Shoenfeld Y
    Harefuah; 2005 Jun; 144(6):415-20, 454, 453. PubMed ID: 15999561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
    Sapir T; Blank M; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on treatment of immunologic abortion with low-dose intravenous immunoglobulin.
    Stricker RB; Winger EE
    Am J Reprod Immunol; 2005 Dec; 54(6):390-6. PubMed ID: 16305665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased pregnancy rates after IVF/ET with intravenous immunoglobulin treatment in women with elevated circulating C56+ cells.
    Coulam CB; Goodman C
    Early Pregnancy (Cherry Hill); 2000 Apr; 4(2):90-8. PubMed ID: 11723539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decline in number of elevated blood CD3(+) CD56(+) NKT cells in response to intravenous immunoglobulin treatment correlates with successful pregnancy.
    van den Heuvel MJ; Peralta CG; Hatta K; Han VK; Clark DA
    Am J Reprod Immunol; 2007 Nov; 58(5):447-59. PubMed ID: 17922698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immunoglobulins.
    Perricone R; Di Muzio G; Perricone C; Giacomelli R; De Nardo D; Fontana L; De Carolis C
    Am J Reprod Immunol; 2006 Mar; 55(3):232-9. PubMed ID: 16451358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin treatment increased live birth rate in a Spanish cohort of women with recurrent reproductive failure and expanded CD56(+) cells.
    Moraru M; Carbone J; Alecsandru D; Castillo-Rama M; García-Segovia A; Gil J; Alonso B; Aguarón A; Ramos-Medina R; Martínez de María J; Oliver-Miñarro D; Rodríguez-Mahou M; Ortega V; Caballero P; Meliá E; Vidal J; Cianchetta-Sivori M; Esteban C; Vargas-Henny L; Dale J; Ortiz-Quintana L; Fernández-Cruz E; Sánchez-Ramón S
    Am J Reprod Immunol; 2012 Jul; 68(1):75-84. PubMed ID: 22509929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin G modulates peripheral blood Th17 and Foxp3(+) regulatory T cells in pregnant women with recurrent pregnancy loss.
    Kim DJ; Lee SK; Kim JY; Na BJ; Hur SE; Lee M; Kwak-Kim J
    Am J Reprod Immunol; 2014 May; 71(5):441-50. PubMed ID: 24645850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiotypic and anti-idiotypic elastin autoantibodies: Implications for IVIg and pregnancy loss.
    Konova E; Atanasova M; Stoykov S; Velkova A; Shoenfeld Y
    J Autoimmun; 2007 Feb; 28(1):46-54. PubMed ID: 17178213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience in IVIg therapy for selected women with recurrent reproductive failure and NK cell expansion.
    Ramos-Medina R; García-Segovia A; Gil J; Carbone J; Aguarón de la Cruz A; Seyfferth A; Alonso B; Alonso J; León JA; Alecsandru D; Meliá E; Carrillo de Albornoz E; Ordoñez D; Santillán I; Verdú V; Garcia Ruiz de Morales JM; López-Hoyos M; López Larios A; Sampalo A; Caballero P; Ortiz Quintana L; Fernández-Cruz E; Sánchez-Ramón S
    Am J Reprod Immunol; 2014 May; 71(5):458-66. PubMed ID: 24612159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss.
    Banjar S; Kadour E; Khoudja R; Ton-Leclerc S; Beauchamp C; Beltempo M; Dahan MH; Gold P; Jacques Kadoch I; Jamal W; Laskin C; Mahutte N; Reinblatt SL; Sylvestre C; Buckett W; Genest G
    Am J Reprod Immunol; 2023 Aug; 90(2):e13737. PubMed ID: 37491929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of IgG therapy on lymphocyte subpopulations in the peripheral blood of Kuwaiti women experiencing recurrent pregnancy loss.
    Mahmoud F; Diejomaoh M; Omu A; Abul H; Haines D
    Gynecol Obstet Invest; 2004; 58(2):77-83. PubMed ID: 15114031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple enumerations of peripheral blood natural killer (CD56+ NK) cells, B cells and T cells have no predictive value in IVF treatment outcome.
    Thum MY; Bhaskaran S; Bansal AS; Shehata H; Ford B; Sumar N; Abdalla HI
    Hum Reprod; 2005 May; 20(5):1272-6. PubMed ID: 15829490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD3-CD56+CD16+ natural killer cells and improvement of pregnancy outcome in IVF/ICSI failure after additional IVIG-treatment.
    Heilmann L; Schorsch M; Hahn T
    Am J Reprod Immunol; 2010 Mar; 63(3):263-5. PubMed ID: 20064143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL).
    Ahmadi M; Abdolmohammadi-Vahid S; Ghaebi M; Aghebati-Maleki L; Afkham A; Danaii S; Abdollahi-Fard S; Heidari L; Jadidi-Niaragh F; Younesi V; Nouri M; Yousefi M
    Biomed Pharmacother; 2017 Aug; 92():1095-1102. PubMed ID: 28622710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK cell frequency and cytotoxicity in correlation to pregnancy outcome and response to IVIG therapy among women with recurrent pregnancy loss.
    Ahmadi M; Ghaebi M; Abdolmohammadi-Vahid S; Abbaspour-Aghdam S; Hamdi K; Abdollahi-Fard S; Danaii S; Mosapour P; Koushaeian L; Dolati S; Rikhtegar R; Oskouei FD; Aghebati-Maleki L; Nouri M; Yousefi M
    J Cell Physiol; 2019 Jun; 234(6):9428-9437. PubMed ID: 30317625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin G infusion treatment for women with recurrent spontaneous abortions and elevated CD56+ natural killer cells.
    Kwak JY; Kwak FM; Gilman-Sachs A; Beaman KD; Cho DD; Beer AE
    Early Pregnancy (Cherry Hill); 2000 Apr; 4(2):154-64. PubMed ID: 11723544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent pregnancy loss: a disease of inflammation and coagulation.
    Kwak-Kim J; Yang KM; Gilman-Sachs A
    J Obstet Gynaecol Res; 2009 Aug; 35(4):609-22. PubMed ID: 19751318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous Immunoglobulin G Improves Pregnancy Outcome in Women with Recurrent Pregnancy Losses with Cellular Immune Abnormalities.
    Lee SK; Kim JY; Han AR; Hur SE; Kim CJ; Kim TH; Cho BR; Han JW; Han SG; Na BJ; Kwak-Kim J
    Am J Reprod Immunol; 2016 Jan; 75(1):59-68. PubMed ID: 26510488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloimmune and autoimmune background in recurrent pregnancy loss - successful immunotherapy by intravenous immunoglobulin.
    Kotlan B; Padanyi A; Batorfi J; Fulop V; Szigetvari I; Rajczy K; Penzes M; Gyodi E; Reti M; Petranyi G
    Am J Reprod Immunol; 2006 May; 55(5):331-40. PubMed ID: 16635207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.